James Peyer, Cambrian BioPharma CEO

Ex­er­cise in a pill? That's the fo­cus of Cam­bri­an's new pipeline com­pa­ny

In line with its an­ti-ag­ing cen­tral theme, Cam­bri­an Bio­Phar­ma has a new clin­i­cal can­di­date to work with, go­ing af­ter what CEO James Pey­er de­scribed as …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.